|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1985-3-18
|
|
pubmed:abstractText |
Cholecystokinin (CCK) binding sites were assessed in post-mortem brain membrane preparations from controls and schizophrenic patients. 125I-BH CCK33 specific binding was reduced by 40% (p less than 0.02) in the hippocampus and by 20% (p less than 0.01) in the frontal cortex of schizophrenic patients compared with controls. There were no differences in 125I-BH CCK33 binding between the two groups in the amygdala, temporal cortex or caudate nucleus.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0024-3205
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
473-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3968973-Adult,
pubmed-meshheading:3968973-Aged,
pubmed-meshheading:3968973-Amygdala,
pubmed-meshheading:3968973-Binding Sites,
pubmed-meshheading:3968973-Caudate Nucleus,
pubmed-meshheading:3968973-Cerebral Cortex,
pubmed-meshheading:3968973-Cholecystokinin,
pubmed-meshheading:3968973-Female,
pubmed-meshheading:3968973-Hippocampus,
pubmed-meshheading:3968973-Humans,
pubmed-meshheading:3968973-Male,
pubmed-meshheading:3968973-Middle Aged,
pubmed-meshheading:3968973-Schizophrenia
|
|
pubmed:year |
1985
|
|
pubmed:articleTitle |
Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
